ESR1 and triple-negative breast carcinoma: The cardinal features of triple-negative breast cancer (TNBC) are that it is aggressive and does not express estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2, presenting significant therapeutic challenges.